Baxter, ASPEN Announce Collaboration to Help Reduce Malnutrition Through Appropriate Use of Parenteral Nutrition Therapy
August 22, 2017
August 22, 2017
DEERFIELD, Ill., Aug. 22 -- Baxter International, a health care company that focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions, issued the following news release:
Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc. (NYSE: BAX), a global leader in nutrition therapy, announced "SmartP . . .
Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc. (NYSE: BAX), a global leader in nutrition therapy, announced "SmartP . . .